Ebola Has Put Africa's Fragile Health Systems in the Spotlight (Economist)

Summary

The worst Ebola outbreak since 2018 (Bundibugyo strain, eastern Congo and Uganda) hit health systems still absorbing the 2025 collapse of American health aid (USAID dissolved; PEPFAR cut). The piece uses the outbreak as a stress test and then reports the "health sovereignty" response: domestic financing, service integration, local manufacturing, and the snags (debt, regulatory fragmentation, data-for-aid deals). Concept page: African Health Sovereignty.

The dependency, in numbers

• Until February 2025 America supplied more than 60% of external public-health funding in Kenya, including the HIV programme.
• Foreign funding for health in Africa has fallen 60% since 2022.
• South Africa: ~15,000 PEPFAR-funded workers all lost their jobs within three months; on 19 June 2026 America said PEPFAR funding for South Africa would end for good.
• Africa imports 70–100% of finished pharmaceuticals and ~99% of vaccines.
• In 2024, 28 African countries spent more on external debt service than on health. In Kenya, each one-point rise in debt-to-GDP cuts long-run health spending by 1.2% (Bajeti Hub analysis).

The outbreak as stress test

• Congo's national biomedical research bureau detected the outbreak late, but then led genomic sequencing of the Bundibugyo strain: a mixed picture of surveillance capacity.
• Cash-strapped neighbours (Kenya) are diverting scarce funds to surveillance and testing.
• Covid had already exposed the weakness of domestic pharmaceutical production; the aid cuts exposed that whole programmes depended on donors for funding, supplies and staff.

The sovereignty response

• Political will moved up a level: support now comes from heads of state, not only health or finance ministers (Naveen Rao, Rockefeller Foundation). Ghana's president John Mahama leads the Accra Reset (more domestic health spending, local manufacturing).
• Domestic financing: more than two-thirds of African governments' 2025 responses to aid cuts were health-related, e.g. paying for drugs (Centre for Global Development). Ghana lifted a cap on health-insurance excise taxes, raising its insurer's budget 60%; Nigeria, Rwanda and Ethiopia are considering alcohol, sugar and tobacco taxes.
• Private and diaspora money: remittances already outstripped aid before 2025 (ONE Campaign wants them routed into health insurance); the EU plans grant-loan-private blends; Tiko in Kenya piloted the first development-impact bond for sexual health (investors repaid only on agreed outcomes), with South Africa next.
• Efficiency through integration: Mozambique's Tete province pooled immunisation, malaria, family planning and other primary care that NGOs had run in parallel ("three different NGO people, in three different hats, doing a single task"); workers now reach "more people, in more places, in less time" (Acasus); being rolled out nationally.
• Manufacturing and R&D: Africa CDC target of 60% of vaccines, diagnostics and therapeutics made locally by 2040; South Africa aims to make lenacapavir (HIV prevention); Nigeria's "all-of-government" production push; a Kenyan factory about to deliver; DNDi-style trials now run across the continent.

What the article flags as unproven or contested

• The money gap is the binding constraint and few governments can close it; the fiscal measures listed are partial.
• Regional cooperation is needed (not every country can be a producer) but South Africa has not joined the African Medicines Agency (operating since 2021), delaying a continental pharma market.
• 22 African countries have signed deals with the Trump administration restoring some health funding in exchange for national health data and, in some cases, mineral rights; the piece calls the road to sovereignty "bumpy" without judging the deals.

Wikilinks

• African Health Sovereignty — concept page.
• Silicon Valleys AI Boom Is Remaking American Charity (Economist) — the vault's other note on falling official aid (USAID) and private donors filling in.
• Childhood Vaccine Schedules — vaccine supply (99% imported) is the other side of the vaccine-confidence story in the US pieces.
• The Economist — Middle East & Africa.

Captured-by trigger

Source file: raw/processed/Economist 2026-06-27 Middle-East---A - Ebola has put Africas fragile health systems in the spo.md.